CD79A and COVID-19: This was consistent with the IgA+ B-cell responses (Figure 3) and suggests that severe patients have a longer memory B cell response for neutralizing BCRs against SARS-CoV-2, where this memory B cell response was proportional to the severity of COVID-19.